Molecular mechanisms underlying the effectiveness of triiodothyroacetic acid (Triac) in patients with resistance to thyroid hormone β (RTHβ): a multicentre, international, retrospective cohort study
Oct 2026· EBioMedicine· Vol 133, pp. 106512· 0 citations· 38 references
Medicine
TL;DR
It is documented that Triac lowers elevated FT4 concentrations in patients with RTHβ effectively and suggested that Triac can act via different modes of action, with activation of the wild-type receptor being a relevant mechanism.
Abstract
Summary Background Disease features in resistance to thyroid hormone beta (RTHβ), caused by THRB mutations, arise from insensitivity to thyroid hormone in tissues expressing thyroid hormone receptor (TR)β and from lifelong thyrotoxic effects in TRα1-expressing tissues, posing substantial cardiovascular morbidity/mortality. The T3-analogue triiodothyroacetic acid (Triac) holds potential as an effective treatment. Systematic data on Triac therapy in RTHβ are lacking, and the mechanisms through which Triac acts are unclear. This study aims to elucidate these knowledge gaps. Methods Clinical and biochemical data were obtained through an, international retrospective cohort study in patients with RTHβ. Transcriptional activity of all TRβ mutants, on the background of the pituitary-expressed β2 receptor isoform and positively (DR+4-TRE) or negatively (TSHα-TRE) regulated reporter genes plus T3 or Triac, was studied. Thyroid function and TSH responses to T3 and Triac were tested in zebrafish expressing TRβ mutants. Findings We collected data from 28 patients with RTHβ (range: 0.4–73.1 years) with 18 unique mutations treated with Triac in 6 centres. Triac reduced TSH (by 43%) and FT4 (by 37%) concentrations in all heterozygous patients, supported by consistent findings in zebrafish. Our functional studies showed that TRβ2 mutants exhibited reduced (all) or absent (G432del) T3-dependent transcriptional activity, with similar EC50 and IC50 values for T3 and Triac, except for R316H, which showed a 5-times lower EC50/IC50 value for Triac compared to T3. Interpretation In this international, multicentre study we have documented that Triac lowers elevated FT4 concentrations in patients with RTHβ effectively. Integrating our clinical and molecular observations we suggest that Triac can act via different modes of action, with activation of the wild-type receptor being a relevant mechanism. Our study may inform clinical management and could shape future interventional studies in patients with RTHβ. Funding Financial support is acknowledged by WL (10.13039/501100015375Affiliated Hospital of Southwest Medical University) WEV (10.13039/501100001826ZonMw (Dutch Research Council, VIDI 09150172210071)), KC (10.13039/100004440Wellcome (210755/Z/18/Z), 10.13039/501100018956NIHR Cambridge Biomedical Research Centre (NIHR20312) and 10.13039/501100000265Medical Research Council United Kingdom (MRC_MU_UU_00014/40)), LP (European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (code: PNRR-MR1-2022-12375726).
Resistance to thyroid hormone alpha (RTHα) is a rare, inherited disorder of thyroid hormone action caused by pathogenic variants in the thyroid hormone receptor alpha gene. Unlike resistance to thyroid hormone beta, RTHα typically presents with near-normal thyroid function tests and a non-elevated thyroid-stimulating h...
Bushra Amer, Albaraa Haidarah, Ahmad Alam et al.· Endocrine Practice· 0 citations
Introduction Resistance to thyroid hormone (TH) β (RTHβ) is a rare genetic disorder caused by mutations in the TH receptor β gene (THRB) and characterized by elevated TH levels with non-suppressed thyroid-stimulating hormone (TSH) and variable clinical presentation. The aim of the study was to characterize the clinical...
Anna Fedorczak, Martyna Sokół, I. Beń-Skowronek et al.· Frontiers in Endocrinology· 0 citations
Type 1 iodothyronine deiodinase (DIO1) plays an important role in peripheral thyroid hormone metabolism, and genetic variation in DIO1 may be associated with differences in thyroid hormone profiles and levothyroxine (LT4) dosing. The present study investigated the association of DIO1 rs2235544 polymorphism with thyroid...
Sara Zuhair Ghani, H. F. Al-zubaidy· Kurdistan Journal of Applied...· 0 citations
Findings provide a theoretical basis for elucidating the TH regulatory mechanism underlying intestinal function in L. polyactis, exerting divergent effects on AA metabolism.
Li-Min Yan, Yao Li, Rui-Han Wu et al.· Comparative Biochemistry and...· 0 citations
Glycoprotein hormone receptors are G-protein-coupled receptors essential for endocrine signaling. Thyroid-stimulating hormone receptor (TSHR), originally expressed in the thyroid gland, has been increasingly detected in various normal and malignant tissues, suggesting a wide range of functions. We hypothesized that ext...
Nasreen Nakad, R. Bar-Shalom, N. Azzam et al.· International Journal of Mol...· 0 citations
Epidemiological evidence regarding the effects of neonicotinoid insecticides (NNIs) exposure on children's thyroid function and the underlying metabolic mechanisms remained scarce. We conducted a longitudinal panel study among children aged 4-12 years to assess associations of 15 urinary NNIs and their metabolites with...
Miao Liu, Kun Huang, Shuo-Shuo Hu et al.· Environmental Pollution· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.